ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Educational Symposium

Knowing Your Options: Understanding Therapies for Hyperkalemia Management to Aid Decision-Making with Patients Treated with Hemodialysis

November 06, 2021 | 12:45 PM - 01:45 PM

Location: Simulive, Virtual Only

Session Description

Hyperkalemia continues to be a significant and common complication among patients who receive hemodialysis. Options for long-term management of hyperkalemia can include restricting dietary potassium, using a bath lower in potassium, stopping RAAS blockers, and initiating potassium binders. However, not all options should be considered for every patient. For example, some patients experience cardiovascular benefits from taking RAAS blockers. Decisions about the management of chronic hyperkalemia should be individualized.

This symposium highlights the considerations dialysis clinicians should make when selecting non-pharmacological and pharmacological options for managing hyperkalemia. Discussion includes an exploration of other benefits of pharmacological options that may aid decision-making.

Support is provided by an educational grant from AstraZeneca Pharmaceuticals.

Learning Objective(s)

  • Describe the factors that contribute to hyperkalemia in patients treated with hemodialysis
  • Identify methods for selecting non-pharmacological approaches to prevent hyperkalemia
  • Discuss the key features of potassium-lowering agents and additional benefits that can contribute to their selection for patients treated with hemodialysis

Learning Pathway(s)

  • Dialysis
  • Cell and Transport Physiology


  • Donald E. Wesson, MD, MBA, FASN